IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 23 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,639 | -42.1% | 1,540 | 0.0% | 0.00% | – |
| Q2 2023 | $4,555 | -27.1% | 1,540 | -31.7% | 0.00% | – |
| Q1 2023 | $6,251 | -85.5% | 2,255 | -72.7% | 0.00% | – |
| Q4 2022 | $42,997 | +48.3% | 8,255 | +9.5% | 0.00% | – |
| Q3 2022 | $29,000 | 0.0% | 7,540 | 0.0% | 0.00% | – |
| Q2 2022 | $29,000 | -23.7% | 7,540 | 0.0% | 0.00% | – |
| Q1 2022 | $38,000 | -5.0% | 7,540 | 0.0% | 0.00% | – |
| Q4 2021 | $40,000 | – | 7,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |